Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Ahmad A
  • Sharma VK
  • MESH
  • Asian Continental Ancestry Group
  • Humans
  • Stroke
  • Tissue Plasminogen Activator

Unbound MEDLINE

More on: optimal dose for stroke thrombolysis in Asians.

Links

  • Publisher Full Text
  • Authors

    Ahmad A, Sharma VK

    Source

    Journal of thrombosis and haemostasis : JTH 10:9 2012 Sep pg 1970-1

    MeSH

    Asian Continental Ancestry Group
    Humans
    Stroke
    Tissue Plasminogen Activator

    Pub Type(s)

    Comment
    Letter

    Language

    eng

    PubMed ID

    22742668

    Related Citations

    • Low-dose versus standard-dose tissue plasminogen activator for intravenous thrombolysis in Asian acute ischemic stroke patients.
    • Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose.
    • Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke.
    • Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
    • Comment on "Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke".
    • Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.
    • Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke.
    • Acute management and research of stroke in Taiwan: an update.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved